Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors.

AUTOR(ES)

Casscells, W

RESUMO

Factors in plasma and platelets do not fully account for the proliferation of smooth muscle cells in vascular injury, implying that additional factors are involved. Recently, we and others have observed that vascular injury regulates basic fibroblast growth factor, suggesting a further role for this pleiotropic factor. We report here that injury of rat arteries leads to an increase in fibroblast growth factor receptors in vascular smooth muscle cells. This up-regulation makes smooth muscle cells susceptible, in vitro and in vivo, to the lethal effects of a conjugate of basic fibroblast growth factor with the ribosome inactivator saporin. Saporin alone has no effect, whereas the conjugate kills proliferating, but not quiescent, smooth muscle cells in vitro. In vivo, one to three doses inhibit neointimal proliferation but have no apparent effect on the uninjured artery. Thus, the up-regulation of fibroblast growth factor receptors in vascular injury suggests new therapeutic possibilities for such refractory conditions as restenosis following balloon angioplasty.

Documentos Relacionados

• Cell transformation by fibroblast growth factors can be suppressed by truncated fibroblast growth factor receptors.
• Elimination of defective alpha-factor pheromone receptors.
• Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor.
• Targeting Gβγ signaling in arterial vascular smooth muscle proliferation: A novel strategy to limit restenosis
• Production of Basic Fibroblast Growth Factor and Interleukin 6 by Human Smooth Muscle Cells following Infection with Chlamydia pneumoniae